An Active Surveillance, Post-Authorization Safety Study to Characterize the Safety of Etrasimod in Patients with Ulcerative Colitis Using Real-World Data in the European Union (C5041046)

ENCePP Code of conduct

Yes

Data sources

• Data source(s):
  German Pharmacoepidemiological Research Database

  PHARMO Data Network

  Other data source
• Data source(s), other:
  Swedish National Health Registers, Swedish Inflammatory Bowel Disease Registry
• Data sources (types):
  Non-interventional study

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Not applicable